PeopleBio, Inc. (KOSDAQ: A304840)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
PeopleBio, Inc. (KOSDAQ: A304840) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.47M.
trading between 561.00 and 2.87K.
Tweenvest scores PeopleBio, Inc. across four factors: quality 35/100, value 49/100. Its strongest factor is value.
A304840 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.47M
- Revenue (TTM)
- $2.48M
- P/E
- —
- EPS
- -696.76
- Dividend yield
- —
- Beta (5Y)
- 0.63
- 52-week high
- ₩2,870.00
- 52-week low
- ₩561.00
- Avg volume (3M)
- —
- Shares outstanding
- 24.26M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Theriva Biologics, Inc.NYSEAM: TOVX | $9.54M | $0.21 | -4.19% |
| Nextage Therapeutics LtdTASE: NXTG | $9.54M | ₪0.37 | -3.95% |
| Solvonis Therapeutics plcLSE: SVNS | $9.53M | £0.00 | -4.76% |
| CRISM Therapeutics CorporationAIM: CRTX | $9.51M | £0.09 | -2.70% |
| AtonENXTPA: ALTAO | $9.46M | €0.01 | -5.56% |
| Lisata Therapeutics, Inc.NasdaqCM: LSTA | $9.28M | $1.03 | -2.83% |
| Celestra Inc.KOSDAQ: A352770 | $9.28M | ₩— | — |
| Cambium Bio LimitedASX: CMB | $9.22M | AU$0.45 | -16.67% |
Figures last refreshed Oct 18, 2026.